These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 18835006)
21. Correlation of central memory CD4+ T-Cell decrease in the peripheral blood with disease progression in SIVmac251-infected Chinese rhesus macaques. Cong Z; Xue J; Xiong J; Yao N; Wang W; Jiang H; Chen T; Chen Z; Wei Q; Qin C J Med Primatol; 2015 Aug; 44(4):175-82. PubMed ID: 25945411 [TBL] [Abstract][Full Text] [Related]
22. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase. Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796 [TBL] [Abstract][Full Text] [Related]
23. Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus. Ho O; Larsen K; Polacino P; Li Y; Anderson D; Song R; Ruprecht RM; Hu SL Retrovirology; 2009 Jul; 6():65. PubMed ID: 19602283 [TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. Batten CJ; De Rose R; Wilson KM; Agy MB; Chea S; Stratov I; Montefiori DC; Kent SJ AIDS Res Hum Retroviruses; 2006 Jun; 22(6):580-8. PubMed ID: 16796533 [TBL] [Abstract][Full Text] [Related]
25. Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques. De Rose R; Mason RD; Loh L; Peut V; Smith MZ; Fernandez CS; Alcantara S; Amarasena T; Reece J; Seddiki N; Kelleher AD; Zaunders J; Kent SJ J Med Primatol; 2008 Dec; 37 Suppl 2():69-78. PubMed ID: 19187433 [TBL] [Abstract][Full Text] [Related]
26. Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection. Gauduin MC; Yu Y; Barabasz A; Carville A; Piatak M; Lifson JD; Desrosiers RC; Johnson RP J Exp Med; 2006 Nov; 203(12):2661-72. PubMed ID: 17116733 [TBL] [Abstract][Full Text] [Related]
27. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia. Kaur A; Hale CL; Noren B; Kassis N; Simon MA; Johnson RP J Virol; 2002 Apr; 76(8):3646-58. PubMed ID: 11907204 [TBL] [Abstract][Full Text] [Related]
28. CD4+ T-cell subsets: what really counts in preventing HIV disease? Mason RD; De Rose R; Kent SJ Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885 [No Abstract] [Full Text] [Related]
29. Lessons learned from the natural hosts of HIV-related viruses. Paiardini M; Pandrea I; Apetrei C; Silvestri G Annu Rev Med; 2009; 60():485-95. PubMed ID: 19630581 [TBL] [Abstract][Full Text] [Related]
30. Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Nishimura Y; Brown CR; Mattapallil JJ; Igarashi T; Buckler-White A; Lafont BA; Hirsch VM; Roederer M; Martin MA Proc Natl Acad Sci U S A; 2005 May; 102(22):8000-5. PubMed ID: 15911767 [TBL] [Abstract][Full Text] [Related]
31. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate. Traina-Dorge VL; Martin LN; Lorino R; Winsor EL; Beilke MA J Infect Dis; 2007 Feb; 195(4):562-71. PubMed ID: 17230416 [TBL] [Abstract][Full Text] [Related]
32. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. Picker LJ; Hagen SI; Lum R; Reed-Inderbitzin EF; Daly LM; Sylwester AW; Walker JM; Siess DC; Piatak M; Wang C; Allison DB; Maino VC; Lifson JD; Kodama T; Axthelm MK J Exp Med; 2004 Nov; 200(10):1299-314. PubMed ID: 15545355 [TBL] [Abstract][Full Text] [Related]
33. Dynamic Modulation of Expression of Lentiviral Restriction Factors in Primary CD4 Rahmberg AR; Rajakumar PA; Billingsley JM; Johnson RP J Virol; 2017 Apr; 91(7):. PubMed ID: 28100613 [TBL] [Abstract][Full Text] [Related]
34. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection. Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380 [TBL] [Abstract][Full Text] [Related]
35. Limited role for the thymus in SIV pathogenesis. Borghans JA; Hazenberg MD; Miedema F Eur J Immunol; 2005 Jan; 35(1):42-5. PubMed ID: 15593304 [TBL] [Abstract][Full Text] [Related]
36. Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut. Wilson DP; Mattapallil JJ; Lay MD; Zhang L; Roederer M; Davenport MP J Virol; 2007 Aug; 81(15):8025-9. PubMed ID: 17507462 [TBL] [Abstract][Full Text] [Related]
37. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299 [TBL] [Abstract][Full Text] [Related]